Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
NKG2D-dependent effector function of bronchial epithelium-activated alloreactive T-cells Source: Eur Respir J 2008; 32: 563-570 Year: 2008
Recognition of pleural mesothelioma by mucin-1(950–958)/human leukocyte antigen A*0201-specific CD8+ T-cells Source: Eur Respir J 2011; 38: 1117-1126 Year: 2011
Neutrophils, interleukin-17A and lung disease Source: Eur Respir J 2005; 25: 159-172 Year: 2005
CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients Source: Eur Respir J 2008; 31: 1167-1176 Year: 2008
Analysis of T and NK lymphocyte phenotypes in patients with tuberculous pleuricy Source: Eur Respir J 2001; 18: Suppl. 33, 307s Year: 2001
Comprehensive characterisation of T helper cells, cytotoxic T cells and novel invariant T cell phenotypes in human asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013
CMV- and EBV-specific CD8+ T cell responses in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
Enhanced cytotoxic function of NK and NKT-like cells associated with decreased CD94 (Kp43) in the airway in COPD Source: Annual Congress 2012 - Basic and translational studies in COPD Year: 2012
Down regulation of ICOS and CTLA 4 on allergic asthmatic T cells upon Derp1 stimulation Source: Annual Congress 2006 - Novel mechanisms in asthmatic inflammation Year: 2006
Phenotypical particularities in asthmatic patients with different genotypes by C-703T (IL-5 gene) and A-80G (IL-5RA gene) polymorphisms Source: Eur Respir J 2001; 18: Suppl. 33, 371s Year: 2001
Lung CD8+ T cells of COPD patients have low cytotoxic potential and high expression of the inhibitory receptor NKG2A Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009
CD4+ and CD8+ T lymphocytes display a Th2/Tc2 cytokine profile in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004
C-C chemokine receptor 2 gene polymorphism V64I and CCR2 expression on T lymphocytes in pulmonary sarcoidosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005
Cytotoxic T cell antigen 4 and the status of T cell activation in lung cancer: local vs. systemic immune response. Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017
CD4+CD25+ T lymphocytes in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 319s Year: 2004
Association of C-703T (IL-5 gene) and A-80G (IL-5RA gene) polymorphisms with bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 370s Year: 2001
Selective NF-κB inhibition of activated/memory (CD45RO+ ) T cells by novel mutated IκBα in asthma Source: Eur Respir J 2007; 30: Suppl. 51, 497s Year: 2007
High fold-changes in peripheral blood PD-1+ CD8+ T cells expressing Granzyme B predicts the response to immunotherapy in NSCLC Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021
Expression of natural killer inhibitory receptors (KIR) on NK and NKT cells in the bronchoalveolar lavage fluid of sarcoidosis patients Source: Eur Respir J 2003; 22: Suppl. 45, 74s Year: 2003